Lucas GM - Search Results

1

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

Spire B, Lucas GM, Carrieri MP. Spire B, et al. Among authors: lucas gm. Int J Drug Policy. 2007 Aug;18(4):262-70. doi: 10.1016/j.drugpo.2006.12.014. Epub 2007 Jan 26. Int J Drug Policy. 2007. PMID: 17689374 Review.

2

Buprenorphine use: the international experience.

Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE. Carrieri MP, et al. Among authors: lucas gm. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S197-215. doi: 10.1086/508184. Clin Infect Dis. 2006. PMID: 17109307 Review.

3

Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058.

Lucas GM, Beauchamp G, Aramrattana A, Shao Y, Liu W, Fu L, Jackson JB, Celentano DD, Richardson P, Metzger D; HPTN 058 study group. Lucas GM, et al. Int J Drug Policy. 2012 Mar;23(2):162-5. doi: 10.1016/j.drugpo.2011.06.005. Epub 2011 Aug 17. Int J Drug Policy. 2012. PMID: 21852093 Free PMC article. Clinical Trial.

4

Overlap between harm reduction and HIV service utilisation among PWID in India: Implications for HIV combination prevention.

Smith MK, Solomon SS, Cummings DAT, Srikrishnan AK, Kumar MS, Vasudevan CK, McFall AM, Lucas GM, Celentano DD, Mehta SH. Smith MK, et al. Among authors: lucas gm. Int J Drug Policy. 2018 Jul;57:111-118. doi: 10.1016/j.drugpo.2018.02.007. Epub 2018 May 3. Int J Drug Policy. 2018. PMID: 29730586 Free PMC article.

5

Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?

Lucas GM, Flexner CW, Moore RD. Lucas GM, et al. AIDS Patient Care STDS. 2002 Nov;16(11):527-35. doi: 10.1089/108729102761041083. AIDS Patient Care STDS. 2002. PMID: 12513901 Review.

6

Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven.

Lucas GM. Lucas GM. J Antimicrob Chemother. 2005 Apr;55(4):413-6. doi: 10.1093/jac/dki042. Epub 2005 Feb 18. J Antimicrob Chemother. 2005. PMID: 15722389 Review.

7

Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.

Lucas GM, Mullen BA, McCaul ME, Weidle PJ, Hader S, Moore RD. Lucas GM, et al. AIDS Patient Care STDS. 2007 Aug;21(8):564-74. doi: 10.1089/apc.2006.0192. AIDS Patient Care STDS. 2007. PMID: 17711381

8

Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.

Celentano DD, Lucas G. Celentano DD, et al. Clin Infect Dis. 2007 Dec 15;45 Suppl 4:S318-23. doi: 10.1086/522557. Clin Infect Dis. 2007. PMID: 18190306

9

Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.

Lucas GM, Chaudhry A, Hsu J, Woodson T, Lau B, Olsen Y, Keruly JC, Fiellin DA, Finkelstein R, Barditch-Crovo P, Cook K, Moore RD. Lucas GM, et al. Ann Intern Med. 2010 Jun 1;152(11):704-11. doi: 10.7326/0003-4819-152-11-201006010-00003. Ann Intern Med. 2010. PMID: 20513828 Free PMC article. Clinical Trial.

10

Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.

Lucas GM. Lucas GM. Life Sci. 2011 May 23;88(21-22):948-52. doi: 10.1016/j.lfs.2010.09.025. Epub 2010 Oct 1. Life Sci. 2011. PMID: 20888839 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters